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Pain is commonplace in newborn infants. Opioid analgesics have become increasingly used to
reduce difrerent types of pain in neonates, including pain from surgery, medical procedures and
chronic conditions. Adverse effects of opioids include respiratory depression, hypotension and
tolerance. These adverse efrects can be minimised by utilising specific administration techniques
and constant monitoring. Recent studies have demonstrated that untreated pain can have long-
term effects on infant pain behaviours months beyond the events, thus, opioid analgesics may have
a beneficial role that extends beyond the immediate painful event(s).
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There are many situations in the life of a newborn infant where pain can occur. These
include medical conditions such as traumatic deliveries and iatrogenic pain during
hospitalisation. Opioid analgesics-have become increasingly utilised in an attempt to
decrease pain in this population.' -" The increase in the utilisation of opioid analgesics for
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neonatal pain management is due to increased awareness that neonates feel pain and that
analgesics effectively decrease pain. In addition, there is a growing body of evidence
demonstrating that untreated neonatal pain can lead to long-term changes in pain beha-
viours that persist throughout infancy and childhood. Recent international consensus
statements have also supported the routine use of analgesics in this population.a's
The purpose of this chapter is to review the literature on pain in the neonate, its
management with opioid analgesics and the long-term effects of untreated pain. The
first part provides a brief overview of the nociceptive system and pain measurement in
newborn infants. In the second part, we review the use of opioid analgesia and research
that deals with the adverse effects of opioids. We conclude with a review of the
literature examining the long-term effects of untreated neonatal pain.
PAIN IN INFANTS
The neonatal nociceptive system
The neuroanatomical basis for pain perception is present at the_time of delivery, even in
preterm infants (for reviews, see Wolfo and Anand et al'). Briefly, it has been
demonstrated that sensory neurons cover all fetal cutaneous and mucosal surfaces by
20 week'gestation.s At full-term, the density of cutaneous neurons in neonatal skin ii
at least as great as that of the adult"' Organisation of the dorsal horn cells and
myelination of nerve tracts up to the level of the thalamus is complete by 30 weeks'
gestation.'' Synaptic connection between the thalamus and cortex occurs at 24 weeks'
gestation." Neuromediators such as substance P and endogenous opioids and their
receptors, have been demonstrated in fetuses as well.
There is remarkable plasticity in the nociceptive system. In general, interplay
between aferent neurons and descending central nervous system neurons modulates
the incoming nociceptive signal, resulting in a dampened or increased nociceptive input.
In the neonate, however, descending central inhibitory pathways and interneurons that
modulate nociceptive inputs in the spinal cord may be relatively immature at birth.l2'13
Consequently, neonates, particularly preterm infants, may respond to stimuli that do
not evoke a response in older, more developed infants and thus may experience pain in
response to normally non-noxious stimuli.
Pain assessment
Newborn infants demonstrate consistent and reliable responses during acutely painful
procedures that. encompass three distinct domains: behavioural, physiological and
neurochemical.'- Behavioural responses include facial grimacing, crying, body writhing
movements and withdrawal reflexes. Physiological responses include changes in heart
rate, oxygen saturation, blood pressure and respiratory rate. Neurochemical
responses include the release of a variety of hormones including cortisol, insulin,
glucagon, endorphin and catecholamines.
In general, infant responses across the different domains are correlated. l5 As such, a
number of composite measures have been developed that incorporate responses from
one or more domains to generate an overall pain score. Examples of infant pain
assessment tools include the Neonatal Facial Coding System (NFCS) | 6, the Premature
Infant Pain Profile (PIPP)r? and the Scale for Use in Newborns (SUN).r8
The responses of infants to acute pain are similar to those observed in children and
adults and are designed to be short-lived and protective. lnfant responses to
persistent or long-lasting pain have been less well,studied. Persistent pain can occur in
certain conditions that involve inflammation '', such as birth-related fractures,
cephalohaematomas, osteomyelitis and necrotising enterocolitis. ln addition, persist-
ent pain may be iatrogenic and result from repeated medical procedures (e.g. heel
lancing). In adults, chronic pain is accompanied by altered sensory states such as
hyperalgesia and allodynia. Similar states probably develop in newborn infants with the
above inflammatory conditions and those exposed to repeated noxious procedures.
In fact" newborn infants may be particularly sensitive to the effects of pain due to the
immaturity of descending inhibitory pathways, rapid brain growth and the potential to
permanently alter neuronal development and organisation.
CLINICAL USE OF OPIOID ANALGESICS
Opioid analgesics are commonly administered to newborn infants for the management
of procedural pain, post-operative pain, disease-related pain and as sedatives to reduce
the stress of intensive care in mechanically ventilated infants. Opioids provide pain relief
and blunt the physiological efects of pain and stress. These include changes in the
cardiorespiratory system (e.g. hypertension, tachycardia, hypoxaemia), endocrine (e.g.
hypothalamic-pituitary-adrenocortical (HPA) activation).. and metabolic processes
(e.g. hyperglycaemia), the immune system and coagulation/hemostasis. I
Opioids decrease the physiological abnormalities that are associated with operative
procedures and may lead to diminished overall morbidity and mortality. In two separate
landmark studies, opioid analgesics were shown to decrease the stress response gnd
improve clinical outcome when used during operative procedures in newborns."''' lt
has been proposed by some authors that the benefits of opioids for operative
procedures may be extrapolated to the neonatal intensive care unit, for indications
such as sedation during mechanical ventilation. In support of this hypothesis are data
demonstrating that cortisol levels in hospitalised^preterm inhnts in the first week of life
can exceed those seen in response to surgery." Moreover, it has been demonstrated
that increased stress hormone concentrations in sick preterm infants are associated
with an increased risk of mortaliry (although it is not clear to what extent they reflect
the severity of underlying illness)." Opioid analgesics have, therefore, been increasingly
used for sedation and analgesia in ventilated preterm infants'- with the hope that they
will improve clinical outcome.
Two studies have investigated the efects of sedation with morphine on infant
outcomes. In a randomised controlled study, Anand et al" found that infants that
received morphine had significantly improved long-term outcomes (defined as a
reduced risk of death and of major neurological morbidity) compared to infants that
received midazolam or dextrose. Infants had been treated with either morphine,
midazolam, or dextrose for up to l4 days (mean infusion duration among groups was
3-5 days). The investigators hypothesised that the beneficial effects of morphine were
due to: decreased stress; blood pressure stability; ventilator synchrony (by decreasing
spontaneous respirations and helping to synchronise breathing during mechanical
ventilation); improved oxygenation.
Similar results, however, were not observed in other randomised controlled trials of
opioid sedation/analgesia in ventilated pre-term infants. Quinn et al26 found a decrease
in pain response but no difference in long-term outcomes when morphine was
compared to placebo. The average duration of morphine therapy was 56 hours.
Similarly, Orsini et al" demonstrated decreases in pain response but not in neonatal
complications using aJentanyl infusion for the first 5 days of life (see also Dyke et al28
and Richardson et al"). None of these studies included enough infants to rule out
Potential long-term (positive or negative) effects of opioid use a-nd further research is
clearly needed before any definite conclusions can be made.
Many studies have demonstrated the efficacy of single doses of opioid analgesics for
decreasing pain and stress during noxious medical procedures, such as percutaneous
venous or arterial catheter placemeng peripheral arterial or venous cutdown,
endotracheal intubation, endotracheal suctioning and chest tube insertion. The reader
is referred to the 'Consensus statement for the prevention and management of pain in
the newborn's for specific details and references.
It should be noted that although opioids are commonly used in neonates, the optimal
dose for a given infant and indication have not been determined. This is due to
insufficient data regarding the concentration-response relationship of opioids. Even
though various pain assessment tools have been developed and validated, there is no
universally accepted method of pain assessment, thus, it has been difficult to assess
pharmacodynamic response in this population. Determination of the concentration-
response relationship also requires that multiple blood samples be collected to assay
drug concentrations. However, ethical considerations limit the number of samples and
total amount of blood that may be collected in neonates for research purposes. lt
should be noted, however, that even if the concentration-response relationship for
opioid analgesics had been well characterised in neonates, developmental differences in
pharmacokinetics and the ontogeny of the nociceptive system make the development
of an appropriate dosage regimen for individual neonates difficult.'u
Adverse effects of opioids
Short term odverse efbcts
The short-term adverse efects of opioid analgesics include respiratory depression,
hypotension, bradycardia, glottic and chest wall rigidity, urinary retention, ileus and
seizures. Although potentially serious and life-threatening, these adverse effects can be
managed clinically. For instance, smaller bolus doses and/or prolonged infusion times
can be used rather than large bolus doses with rapid iniection times. In addition,
combining opioid analgesics with interacting medications can be avoided. One such class
of drugs are the benzodiazepines, which, when combined with opioids, increase the risk
of hypotension and respiratory depression.'' Furthermore, opioid use can be limited to
infants receiving ventilatory support, so that respiratory depression is easi} managed.
Toleronce
Chronic administration of opioids may be associated with tolerance that requires dose
escalation to maintain analgesia and sedation. Tolerance occurs in patients that are given
opioid analgesics on a long-term basis. The rate of development of tolerance is variable
between patients, but may be as short as a few days after the beginning of therapy.
Tolerance is believed to develop more rapidly with continuous infusions of opioids
(rather than intermittent doses) and with the use of synthetic opioids (e.g. fentanyl)."
According to various authors, the development of tolerance to fentanyl in neonates
occurs after a cumulative 
-fentanyl dose of 1.6-2.5 mg/kg, or after 5-9 days of
continuous infusion therapy."''* lt has been suggested that the risk of developing opioid
tolerance may be reduced by instituting other comfort measures concurrently that
supplement opioid analgesia/sedation such as noise reduction35, or by switching opioids
and' using sedatives (if ippropriate).32
Withdrawol reoctrons
Abrupt discontinuation of opioid analgesics may be accompanied by withdrawal
reactions in infants that, are physiologically dependent. The main body systems affected
in opioid withdrawal include the central nervous system, autonomic system and
gastrointestinal system. In one retrospective study of the frequency of adverse effects
following opioid use in neonates for > 3 days, the most frequently observed symptoms
were irritability, hypertonicity, diaphoresis, hyperrhermia and vomiting with feeds.'u Of
the | 8 neonates given morphine, 48% experienced withdrawal reactions as did 84% of
the 15 neonates who received fentanyl. Withdrawal reactions were correlated with
dose and duration of infusion and lasted from I to | | days. Fentanyl was associated with
a longer duration of withdrawal (mean : 3.9 days) compared to morphine (mean : 2.3
days).
Some authors have suggested tapering schedules for discontinuation of opioids. The
rationale for this being that gradual removal of the drug will prevent withdrawal
reactions. At preseng there are no experimental data supporting one tapering method
over another and individual patient needs should be considered. In general, more
aggressive tapering schedules are advised for patients that have received short-term
therapy compared to those taking opioids for longer durations. For short-term therapy,
opioid doses are decreased by approximately25-50% of the dose per day and the drug
is discontinued within 2-3 days. Doses are decreased by 10-20% of tlre original dose
per day for long-term therapy and infusion regimens may be switched to intermittent
dosing regimens before discontinuation. An approach to weaning opioid infusions was
recently published by Anand et al." The same opioid that was used therapeutically is
usually used during the weaning process. Continual observation and evaluation of
withdrawal reactions is necessary throughout the tapering period. Many neonatal
intensive care units have implemented tapering protocols to facilitate the process."
They use objective tools to monitor symptoms (for a review, see Suresh and Anand32)
and tailor opioid dosing requirements accordingly. Withdrawal reactions are managed
with opioids. Non-pharmacological interventions were added to supplement their
effects. Non-opioid medications are less frequently used to manage withdrawal
reactions.32'37
Beh avi ou rol disturbonces
There has been a long-standing concern that using opioid analgesics in the neonaral
period may lead to disturbances in parental-infant attachment and imprinting. These
concerns are derived from studies of the ontology of various neurotransmitter systems
in the nervous system demonstrating extensive postnatal development with increased
plasticity in the neonate compared to the adult. Detrimental effects have been
demonstrated in human and animal studies (see Rahman et al38 and MacGregor et al3e).
Briefly, human studies have shown that infants born to opioid-abusing mothers may
have cognitive and behavioural problems (although these data are confounded by other
risk factors associated with drug abuse). Animal studies have demonstrated altered
receptor number, analgesia and tolerance in the adult following exposure in early life.
It should be noted, howeven that is possible that non-medical opioid exposure in the
neonatal period may lead to different pharmacological efects compared to when it is
used for painful conditions.'o In a study that investigated long-term neurological and
behavioural outcome in newborn infants exposed to opioids during clinical care (for
56 hours to 5 days), no adverse effects were observed. Infants who received morphine
(n : 57) were not different from those who did not (n : 30) in intelligence quotient
(lQ), motor impairment or behaviour problems. In fact, there was a trend for better
scores in the morphine-exposed group." Moreover, it has been suggested that clinical
use of opioids in neonates is,pr,otective against potential adverse long-term efects of
untreated pain (see below).'"--' Clearly, more research on the long-term effects of
opioid analgesia are needed.
Centrol sensitisction
There is a growing body of basic science and clinical data in the adult literature
describing the development of acute opioid tolerance and its relationship to opioid-
induced facilitation. Recent advances in the basic science of pain are relevant to the
efforts to prevent central sensitisation by preoperative administration of opioids.
Opioid administration may lead to the development of acute opioid tolerance43'44
and opioid-induced hcilitation of nociceptive processingas-<t thereby increasing the
requirements for postoperative analgesia and enhancing postoperative pain. The effects
ofopioid agonist-induced hyperalgesia are operating at cross-purposes to the analgesic
effects thereby reducing the overall magnitude of the analgesic efects of these agents.
Strategies to maximise pain relief and minimise the development of acute
opioid tolerance and opioid induced hypersensitivity include co-administration of
N-methyl-o-aspartate (NMDA) receptor antagonists such as low-dose ketamineas'ae or
dextromethorphan and ultra low-dose opioid antagonists such as naloxone or nal-
trexone."''' To our knowledge there are no studies in the infant literature that address
the related issues of acute opioid tolerance, opioid-induced facilitation of nociceptive
processing and their reversal by opioid antagonists or NMDA receptor antagonists.
LONG.TERM EFFECTS OF PAIN
The increase in utilisation of opioid analgesia for the management of pain in the neonate
is supported by recent evidence suggesting that early pain experience results in
behavioural and physiological changes in future pain responses. These studies can be
divided into two groups: studies that investigated the effects of prolonged or repeated
pain and those that investigated the effects of a single painful event. A brief review of
their findings is provided below.
Efrects of a single painful event
Studies on the long-term effects of a single painful event have focused on the effects of
birth conditions and neonatal surgical procedures on pain responses during routine
immunisation. lt has been demonstrated that highly stressful, or suboptimal, birth
conditions are associated with exaggerated cortisol responses to routine immunisation
up to the age of 6 months."''" Two studies have shown that male neonatal circumcision
is associated with heightened pain responses during routine immunisation 4-6 months
later."'" In one of these studies, pre-treatment of circumcision pain with local
anaesthesia partially attenuated the development of these heightened pain beha-
viours." Most recently, Peters et al-" demonstrated no difference in immunisation pain
responses at l4 or 45 months between infants that had undergone major abdominal or
thoracic surgery in the first 3 months of life and control infants. In the surgical group,
infants had received morphine for post-operative pain and morphine administration
may have prevented the development of alterations in pain threshold in the long term.
In summary, heightened behavioural responses to pain have been observed in
neonates undergoing noxious procedures compared with neonates not subjected to
these procedures. The results of one study suggest that the administration of a local
anaesthetic during neonatal surgery obtunded the pain response to the subsequent
procedure several months later, implying a causal relationship between the two
experiences of pain.
Effects of prolonged or repeated pain
Several groups of investigators have examined the pain responses of preterm and full-
term newborn infants that had undergone multiple painful procedures during
hospitalisation in the neonatal intensive care unit. lt has been demonstrated that
both behavioural and physiological responses to pain may be altered over time although
the direction of the changes that are observed is not always consistent for a given
variable and changes in pain response are not consistently predicted by the number of
painful procedures that the infants were exposed to. Differences in study designs and
environmental conditions may explain the inconsistent findings. These studies are
described in more detail below.
A recent study found that infants with pathological abdominal disease (unilateral
hydronephrosis) demonstrated cutaneous abdominal sensitivity when compared to
normal infants and that this hypersensitivity persisted up to 3 months after corrective
surgery, suggestive of visceral hypersensitivity.s6 Howevel Anand and BirchsT found
no evidence of chronic pain behaviour or neuropathic pain syndromes in children and
adults 3-23 years after brachial plexus injury at birth and speculated that relative
neuronal immaturity in the newborn and central nervous system plasticity is
protective against the subsequent development of chronic pain syndromes.t'
In a study byJohnston and Stevens'o, the behavioural and physiological pain response
patterns of preterm infants born at 32 weeks gestational age were found to differ from
those of preterm infants aged 32 week who had been born 4 week earlier. The earlier-
born infants demonstrated significantly less behavioural grimacing (i.e. brow bulge, eye
squeeze, naso-labial furrow) compared to the newly born infants. Earlier-born infants
exhibited significantly higher maximum heart rates and lower oxygen saturation values
than the newly born infants. More recently, Grunau et al*' found that exposure to a
greater number of painful procedures correlated with diminished facial reactivity as well
as heart rate variability during heel lance in preterm infants. Increased heart rate
variability, howeve6 was associated with increased exposure to morphine. These
authors suggest that increased exposure to painful procedures diminished the pain
response and that morphine exposure partially ameliorated these effects.
Three longitudinal studies have demonstrated that pain responses change over time
in preterm infants exposed to repeated painful procedures as neonates. Fitzgerald
et al" used the flexion reflex threshold (a nociceptive reflex involving noxious stimulus
elicited limb withdrawal) to demonstrate that tactile responses were heightened in
preterm infants after undergoing repeated painful cutaneous procedures. This
hypersensitivity was prevented by pre-treatment of the damaged area with a topical
anaesthetic cream. Johnston et al"' and Porter et alo' demonstrated increased
behavioural responses in preterm infants over time.
To date, two studies have evaluated pain behaviours in former extremely low
birthweight (ELBW) infants (=gOO g) undergoing a procedure after discharge from the
neonatal intensive care unit. Both studies included the same cohort of infants at 4 and 8
months corrected agu.o''" In both studies, behavioural and physiological responses
were similar between former ELBW infants and term-born control infants. However,
subtle differences in cardiac, autonomic and facial responses were observed.
While it has been suggested that early pain may cause changes in the processing of
nociceptive stimuli, it is important to consider the role of classical conditioning in
inducing these changes. lt may be that infants learn to anticipate an impending noxious
event and, therefore, exhibit anticipatory pain behaviours and it is these behaviours,
rather than sensitisation of nociceptors and/or central sensitisation (hyperexcitability)
of sensory structures involved in processing somatosensory input that accounts for the
observed differences in pain behaviour over time. Few studies have examined this
phenomenon. In one study, preterm infant responses to having their leg being picked
up prior to heel lance were recorded over time.o' Heaft rate changes increased over
time, supporting a conditioning theory. However, facial grimacing and body movements
did not change over time. More recently, Taddio et al6a demonstrated conditioning and
hyperalgesia in full-term newborns exposed to repeated heel lances. Unlike the
previous study, this study included a group of infants that experienced repeated pain
and a control group that did not experience repeated pain. Investigators found that
infants exposed to repeated heel lances had greater behavioural pain responses during
the preparatory phase ofavenipuncture (i.e. skin cleansing) and thatthe intensity ofthe
pain they experienced in response to venipuncture was greater than that of normal
infants.
CONCLUSION
Newborn infants have the capacity to perceive pain. Furthermore, their responses to
pain can be objectively quantified. lt is generally accepted that pain relief should be a
part of the medical management of preterm and full-term infants. The major
justifications for this view include the accumulating evidence that analgesics effectively
decrease pain and that untreated pain and stress may have long-lasting effects on
subsequent pain responses later in infancy. Opioid analgesics have been increasingly
used to manage procedural pain, post-operative pain, disease-related pain and the
stress of intensive care in mechanically ventilated infants. They may, however, be
associated with serious adverse effects. In addition, the optimum dose is not known.
Early experiences with pain may be associated with heightened or dampened pain
responding later in infancy, depending, in part, on the infant's current state,
developmental status (e.g. pre-term versus full term) and cumulative experience with
pain. Preterm infants thatare hospitalised as neonates and subjected to repeated painful
procedures appear to have a dampened response to subsequent painful procedures
later in infancy. In contrast, full-term infants exposed to extreme stress during delivery
or who undergo surgery react to later noxious procedures with heightened
behavioural responsiveness. Variability in infant characteristics, time frame within
which infants were observed and outcome measures may explain certain discrepancies
between study outcomes. lt appears that there is the potential for early neonatal pain
experience to cause changes in how infants respond to future painful procedures. The
precise determinants of these changes, their extent and their permanence are not
known but they appear to involve noxious stimulus induced peripheral and central
sensitisation as well as classical conditioning. Continued investigation of the effects of
early pain on nociceptive pathways and the potential effects of pre-treatment with
opioid analgesics are needed.
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